Study guide

12.2 Normal Mechanical and Bioprosthetic Valve Assessment

CCI Registered Cardiac Sonographer RCS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: RCS Orientation and Clinical Context

1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context

2 Chapter 2: Orders, Safety, and Patient Preparation

2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare

3 Chapter 3: Reporting and 2-D TTE Foundations

3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA

4 Chapter 4: M-Mode and Doppler Acquisition

4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition

5 Chapter 5: Advanced Doppler and Contrast

5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts

6 Chapter 6: Stress Echocardiography

6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation

7 Chapter 7: TEE, Strain, and 3-D TEE

7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts

8 Chapter 8: 3-D TTE and the Aortic Valve

8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States

9 Chapter 9: Aortic Regurgitation and Mitral Structure

9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability

10 Chapter 10: Mitral and Tricuspid Valve Findings

10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment

11 Chapter 11: Right-Sided Valve Disease

11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment

12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves

12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch

13 Chapter 13: Endocarditis and Cardiac Chambers

13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function

14 Chapter 14: Cardiomyopathy Phenotypes and Diastology

14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls

15 Chapter 15: Systolic Function and Ischemia

15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications

16 Chapter 16: Pericardium and Great Vessels

16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation

17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition

17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues

18 Chapter 18: Devices, Strain, and Hemodynamics

18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts

19 Chapter 19: Infiltrative Disease and Physics Foundations

19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing

20 Chapter 20: Resolution and Doppler Optimization

20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain

21 Chapter 21: 2-D, 3-D, and Contrast Optimization

21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts

12.2 Normal Mechanical and Bioprosthetic Valve Assessment

Key Takeaways Explain This Topic AI

Before scanning, obtain prosthesis position, manufacturer and model when available, mechanical or bioprosthetic type, labeled size, implant date, surgical or transcatheter method, and any valve-in-valve or conduit details.

The most useful comparator is the patient's stable postoperative baseline; expected velocities, gradients, DVI, and EOA vary by valve design, size, position, body size, heart rate, and flow.

A normal examination combines unrestricted leaflet or occluder motion, stable sewing ring or stent, appropriate Doppler hemodynamics, expected physiologic regurgitation, and absence of adverse chamber response.

Use multiple windows and recognize reverberation, shadowing, pressure recovery, and bileaflet central-orifice velocity before labeling a normal mechanical or tissue prosthesis abnormal.

Last updated: July 2026

Identify the prosthesis before judging it

CCI task C13 includes assessment of prosthetic valves. Start by retrieving the operative note, device card, and prior studies. Record valve position; manufacturer and model when known; mechanical, surgical bioprosthetic, homograft, or transcatheter design; labeled size; implant date; and whether it is valve-in-valve, valve-in-ring, root replacement, or a valved conduit. Document symptoms, blood pressure, heart rate, rhythm, height, weight, body surface area, and relevant anticoagulation information. For atrioventricular prostheses, heart rate materially affects diastolic filling and mean gradient.

The baseline TTE should have been obtained after implantation under stable hemodynamic conditions. It records the patient's normal leaflet or occluder motion, velocity, mean gradient, DVI, effective orifice area (EOA), regurgitation, and chamber response. Compare today's data with that baseline and with reference values for the same type and size. A generic cutoff cannot account for design: a small mechanical valve normally has different hemodynamics from a larger stented tissue or transcatheter valve. Never use labeled size as the measured LVOT diameter.

Mechanical designs include contemporary bileaflet valves and less common single tilting-disk or older caged-ball valves. They are durable but generate strong reverberation and shadow. Bileaflet valves divide forward flow into one small central and two larger lateral orifices; CW may capture the high-velocity central jet and overestimate gradient, especially in a small valve or high-flow state. Bioprostheses use tissue leaflets mounted on a stent, implanted without a stent, placed as a homograft, or deployed by catheter. Tissue cusps are more directly visualized but can still be obscured by the frame or calcification.

Image structure, motion, stability, and expected leakage

Use standard and off-axis views that place the prosthesis in long and short axis. Sweep through the entire sewing ring or stent rather than relying on one plane. Describe opening and closing of every demonstrated leaflet or occluder, tissue thickness and echogenicity, calcification, unexpected masses, frame shape and position, and surrounding anatomy. A stable ring moves with its annulus; independent excessive rocking plus a paravalvular jet raises concern for dehiscence. Immediately postoperative edema or hematoma and pledgets can resemble pathologic tissue, making the early baseline essential.

Mechanical valves require small intentional washing jets to reduce stasis. These are usually narrow, predictable, symmetric intravalvular jets defined by the design. Do not call them pathologic simply because color is present. Conversely, do not dismiss a new, broad, eccentric, or paravalvular jet as washing flow. A normal tissue valve may have trivial central closure regurgitation, but a visible gap, leaflet tear, or jet outside the sewing ring is not physiologic. Map jet origin in multiple views and distinguish intravalvular from paravalvular flow.

Prosthesis position Core Doppler acquisition Essential context

Aortic Multiwindow CW velocity, contour, mean gradient, VTI, acceleration time; LVOT PW for DVI and EOA Stroke volume, BP, LV function, pressure recovery, exact device

Mitral Peak E velocity, mean gradient, prosthetic VTI, PHT; LVOT VTI for DVI and EOA Heart rate, rhythm, MR, LA/LV/RV size, pulmonary pressure

Pulmonary PW localization plus CW peak/mean gradient and DVI when feasible RV stroke volume, conduit/branch stenosis, RV pressure and function

Tricuspid Peak velocity, mean gradient and PHT over respiratory cycles Heart rate, rhythm, respiration, TR, RA/RV and hepatic flow

Calculate matched hemodynamics

Record the highest valid forward velocity from all appropriate windows; for an aortic prosthesis, use a nonimaging probe when it improves alignment. Trace the dense modal CW envelope. Peak and mean gradients are flow dependent. Calculate continuity EOA as:

EOA = forward stroke volume / prosthetic-valve VTI

The diameter and PW sample must describe the same flow location. In a surgical aortic valve, sample just proximal to the prosthesis without including acceleration. A transcatheter frame can accelerate flow at its inlet and again at the cusps, so follow the recommended matched diameter and PW convention and preserve it for serial studies. LVOT diameter error is squared.

For an aortic prosthesis, DVI = LVOT VTI / prosthetic aortic VTI . It avoids the diameter term but remains wrong if the LVOT sample contains acceleration or is too apical. Record CW contour, acceleration time, and acceleration-time/ejection-time ratio as additional shape and timing evidence. A normal prosthetic aortic signal is usually triangular and early peaking rather than rounded and late peaking.

For a mitral prosthesis, the VTI ratio is inverted: DVI = prosthetic mitral VTI / LVOT VTI . Report the heart rate for the mean gradient. PHT describes pressure decay but is affected by chamber compliance and is not used as a shortcut for continuity EOA. Significant MR can raise mitral velocity and DVI while lowering systemic LVOT flow, so even a normal-looking prosthesis needs a regurgitation screen.

Complete the study with LV and RV size and systolic function, atrial size, wall thickness, other valve disease, estimated pulmonary pressure, venous flow when relevant, and a search for paravalvular complications. Archive representative 2-D, color, PW, and CW data with ECG and settings. A normal report names the valve, size, date, baseline comparison, observed motion and stability, measured hemodynamics, expected physiologic leakage, chamber findings, and limitations. TTE is first line; TEE, CT, fluoroscopy, or CMR is reserved when structure, motion, or flow cannot be resolved adequately.